MedPath

Treatment of acute post-Anserin bursitis with topical injection of corticosteroids and high-level laser therapy

Phase 3
Conditions
pes anserine bursitis knee.
Rheumatoid bursitis, knee
M06.26
Registration Number
IRCT20151123025202N19
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Diagnosis of PAB according to clinical criteria and imaging by a specialist physician
At least 3 months after diagnosis
Age 18-65 years
Minimum pain intensity according to VAS> 3

Exclusion Criteria

Comorbidity with other diseases such as: advanced osteoarthritis, infection, neurological and motor diseases (stroke, Parkinson's, myopathies, neuropathies, ....), other systemic diseases such as rheumatoid arthritis and heart disease
History of recent knee surgery or trauma
Treatment with corticosteroid now or during the last 4 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pes anserine bursitis thickness changes. Timepoint: Before treatment, one month later, and three months after treatment. Method of measurement: sonography.;Pain severity of knee. Timepoint: Before treatment, one month later, and three months after treatment. Method of measurement: By Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
Patients Quality of life. Timepoint: Before treatment, one month and three months after starting treatment. Method of measurement: With SF-12 Quality of Life Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath